Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial

The WHO ACTION-I trial, the largest placebo-controlled trial on antenatal corticosteroids (ACS) efficacy and safety to date, reaffirmed the benefits of ACS on mortality reduction among early preterm newborns in low-income settings. We discuss here lessons learned from ACTION-I trial that are relevan...

Descripción completa

Detalles Bibliográficos
Autores principales: De Costa, Ayesha, Oladapo, Olufemi T., Gupta, Shuchita, Portela, Anayda, Vogel, Joshua P., Souza, Joao Paulo, Rao, Suman, Minckas, Nicole, Tuncalp, Özge, Bahl, Rajiv, Althabe, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798686/
https://www.ncbi.nlm.nih.gov/pubmed/36578090
http://dx.doi.org/10.1186/s12961-022-00941-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798686/
https://www.ncbi.nlm.nih.gov/pubmed/36578090
http://dx.doi.org/10.1186/s12961-022-00941-z

Ejemplares similares